DJIA 16,628.94 -25.83 -0.16%
NASDAQ 4,828.43 15.72 0.33%
S&P 500 1,991.20 3.54 0.18%
market minute promo

Gilead Sciences (NASDAQ: GILD)

108.38 0.39 (0.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $108.16 0.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $106.96
Previous Close $107.99
Daily Range $106.82 - $108.79
52-Week Range $85.95 - $123.37
Market Cap $159.1B
P/E Ratio 11.36
Dividend (Yield) $1.72 (1.6%)
Ex-Dividend Date
Dividend Pay Date
09/14/15
09/29/15
Volume 3,468,817
Average Daily Volume 11,130,411
Current FY EPS $11.99

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

Bouncing Biotech? 3 Stocks To Buy

It may be time to consider buying Gilead Sciences, Celgene Corp, and Regeneron on sale.

Benzinga's M&A Chatter for Thursday August 27, 2015

12 Attractive Fast-Growing Dividend Growth Stocks for High Total Return

12 Attractive Fast-Growing Dividend Growth Stocks For High Total Return

Biogen And Gilead Sciences Catch The Eye Of Short Sellers

What To Buy Now

J&J to Sell Sugar Substitute Splenda to Heartland Food

Novartis' (NVS) Promacta Label Further Expanded in U.S.

Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary Art

Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary Arterial Hypertension Published in The New England Journal of Medicine

Short Sellers Become More Focused in Major Biotechs

The Worst Is Over, 5 Reasons To Get Ready For A 'V' Shaped Rally

See More GILD News...

GILD's Top Competitors

GILD $108.38 (0.36%)
Current stock: GILD
AMGN $155.44 (-0.18%)
Current stock: AMGN
CELG $123.61 (0.46%)
Current stock: CELG
$0.00 (0.00%)
Current stock: